Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade
International Journal of Biological Sciences · 2023
DOI: 10.7150/ijbs.87182 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2023. Verfasst von Jiancheng Lv und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. Hauptthemen laut MEDLINE: Lysine, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The immunotherapy sensitivity of patients with bladder cancer (BCa) remains low. As the role of protein methylation in tumorigenesis and development becomes clearer, the role of lysine N-methyltransferase SET domain containing 7 (SETD7) in the progression and immune escape of BCa is worth studying.
Methods
The correlation between lysine methyltransferase family and prognosis or immunotheray sensitivity of BCa patients were analyzed, and SETD7 was screened out because of the significant correlation between its expression and survival data or immunotherapy sensitivity. The expression of SETD7 in BCa tissues and cell lines were explored. The functions of SETD7 were investigated by proliferation and migration assays. The role of SETD7 in BCa immune escape was validated by analyzing the correlation between SETD7 expression and tumor microenvironment (TME)-related indicators. The results were further confirmed by conducting BCa cell-CD8+ T cell co-culture assays and tumorigenesis experiment in human immune reconstitution NOG mice (HuNOG mice). Bioinformatic prediction, CO-IP, qRT-PCR, and western blot were used to validate the SETD7/STAT3/PD-L1 cascade.
Results
SETD7 was highly expressed in BCa, and it was positively associated with high histological grade and worse prognosis. SETD7 promoted the proliferation and migration of BCa cells. The results of bioinformatics, in vitro co-culture, and in vivo tumorigenesis assays showed that SETD7 could inhibit the chemotoxis and cytotoxicity of CD8+ T cells in BCa TME. Mechanistically, bioinformatics analysis, CO-IP assay, qRT-PCR, and western blot results indicated that SETD7 could increase the expression of PD-L1 via binding and promoting STAT3.
Conclusions
Taken together, SETD7 indicated poor prognosis and promoted the progression and immune escape of BCa cells. It has great potential to act as a new indicator for BCa diagnosis and treatment, especially immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Zitieren
APA
Lv, J., Wu, Q., Li, K., Bai, K., Yu, H., Zhuang, J., Sun, H., Yang, H., Yang, X., & Lu, Q. (2023). Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.87182
Vancouver
Lv J, Wu Q, Li K, Bai K, Yu H, Zhuang J, et al. Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade. International Journal of Biological Sciences. 2023. doi:10.7150/ijbs.87182
BibTeX
@article{Lv2023,
author = {Lv, Jiancheng and Wu, Qikai and Li, Kai and Bai, Kexin and Yu, Hao and Zhuang, Juntao and Sun, Huanyou and Yang, Haiwei and Yang, Xiao and Lu, Qiang},
title = {Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade},
journal = {International Journal of Biological Sciences},
year = {2023},
doi = {10.7150/ijbs.87182}
}
EUVIMED